Literature DB >> 1756482

Establishment and characterization of a new Ewing's sarcoma cell line.

K Kodama1, O Doi, M Higashiyama, Y Mori, T Horai, R Tateishi, Y Aoki, S Misawa.   

Abstract

A new human Ewing's sarcoma cell line (CADO-ES1) was established from the malignant pleural effusion of a 19-year-old woman. These cells grew both anchorage dependently and anchorage independently. When cultured in bacteriologic dishes, they grew as tightly packed multicellular tumor spheroids; they were also capable of proliferating in soft agar. Flow cytometric DNA analysis demonstrated a nearly diploid DNA content (DNA index = 0.902). Chromosomal studies of cultured cells showed an isodicentric chromosome 8 in all examined cells, but t(11;22)(q24;q12), a translocation reported previously in Ewing's sarcoma, was not detected. Under normal culture conditions, no morphologic evidence of neural differentiation was detected. In addition, immunocytochemical studies showed that vimentin was intensely positive, whereas neurofilament (NF) and neuron-specific enolase (NSE) were weakly positive. Treatment with cyclic AMP (cAMP) induced pronounced morphologic evidence of neural differentiation and strong expression of NF in cultured cells. S-100 protein, glial fibrillary acidic protein (GFAP), desmin, cytokeratin, and epithelial membrane antigen were not detected immunohistochemically in either untreated or cAMP-treated cells, however. These data suggest that this cell line is derived from a highly undifferentiated neural cell with high chromosomal clonality, differentiating into neural features under certain conditions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1756482     DOI: 10.1016/0165-4608(91)90185-w

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

Review 1.  Intermediate filaments in the nervous system: implications in cancer.

Authors:  C L Ho; R K Liem
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

2.  Molecular cytogenetic characterization of two established ESFT cell lines.

Authors:  Masako Ishiguro; Mutsumi Yuki; Tomoko Fukushige; Mikio Mizoguchi; Yasuhiko Kaneko; Takeshita Morishige; Hiroshi Iwasaki
Journal:  Hum Cell       Date:  2016-09-09       Impact factor: 4.174

3.  Molecular Approaches to Diagnosis in Ewing Sarcoma: RT-PCR.

Authors:  Carlos Rodríguez-Martín; Javier Alonso
Journal:  Methods Mol Biol       Date:  2021

4.  Explant culture of sarcoma patients' tissue.

Authors:  Roman Muff; Sander M Botter; Knut Husmann; Joelle Tchinda; Philomina Selvam; Franziska Seeli-Maduz; Bruno Fuchs
Journal:  Lab Invest       Date:  2016-04-25       Impact factor: 5.662

5.  Splice variants denote differences between a cancer stem cell side population of EWSR1‑ERG‑based Ewing sarcoma cells, its main population and EWSR1‑FLI‑based cells.

Authors:  Eberhard Korsching; Julian Matschke; Marc Hotfilder
Journal:  Int J Mol Med       Date:  2022-01-28       Impact factor: 4.101

6.  Differentiation of a Ewing's sarcoma cell line towards neural and mesenchymal cell lineages.

Authors:  K Kodama; O Doi; M Higashiyama; H Yokouchi; R Tateishi; Y Mori
Journal:  Jpn J Cancer Res       Date:  1994-04

7.  TRIM69 Inhibits Vesicular Stomatitis Indiana Virus.

Authors:  Suzannah J Rihn; Muhamad Afiq Aziz; Douglas G Stewart; Joseph Hughes; Matthew L Turnbull; Mariana Varela; Elena Sugrue; Christie S Herd; Megan Stanifer; Steven P Sinkins; Massimo Palmarini; Sam J Wilson
Journal:  J Virol       Date:  2019-09-30       Impact factor: 6.549

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.